title: Change in caspase-3-like protease in the liver and plasma during rat liver regeneration following partial hepatectomy.
abstract: Recent studies have shown that many factors orchestrate liver regeneration after a two-thirds partial hepatectomy (PH). However, the termination mechanism in liver regeneration has not been thoroughly studied. In this paper, we report that the activity of liver caspase-3-like protease, which is specifically activated in apoptosis, increases 18, 36, and 48 hr after PH during maximal hepatocyte proliferative activity. This is the first study that shows the activation of an apoptosis-executing enzyme during physiological liver regeneration. These results suggest that apoptosis is induced in each surge of DNA synthesis as the termination mechanism. When phenoxybenzamine, an alpha-blocker that has been reported to inhibit DNA synthesis during liver regeneration, was injected 8 hr after PH, the caspase-3-like activity in the liver peaked at 15 hr after PH and the enzyme activity also increased in plasma at 18 and 24 hr after PH in sharp contrast to the case of normal regeneration. These results indicate that extensive apoptosis is caused by phenoxybenzamine and that the secondary necrosis of apoptotic cells results in the increase of caspase-3-like protease activity in the plasma.
authors: Department of Food Science and Nutrition, Nara Women's University, 630-8506, Nara, Japan.
authors: S
authors: S
authors: Hayami
authors: M
authors: M
authors: Yaita
authors: Y
authors: Y
authors: Ogiri
authors: F
authors: F
authors: Sun
authors: R
authors: R
authors: Nakata
authors: S
authors: S
authors: Kojo
mesh_terms: D000818:Animals; D017209:Apoptosis; D001219:Aspartate Aminotransferases / Q000097:blood; D053148:Caspase 3; D020169:Caspases / Q000097:blood / Q000378:metabolism*; D004247:DNA / Q000096:biosynthesis / Q000187:drug effects; D006498:Hepatectomy; D008099:Liver / Q000187:drug effects / Q000201:enzymology* / Q000473:pathology / Q000601:surgery; D008115:Liver Regeneration / Q000187:drug effects / Q000502:physiology*; D008297:Male; D019384:Nucleic Acid Synthesis Inhibitors / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D016196:S Phase / Q000502:physiology
chemical_list: D019384:Nucleic Acid Synthesis Inhibitors; D010643:Phenoxybenzamine; D004247:DNA; D001219:Aspartate Aminotransferases; C505410:Casp3 protein, rat; D053148:Caspase 3; D020169:Caspases